MEGAN ALDERMAN: Open Payments
NPI 1780318709 · WOODLAWN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,723 in 94 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $461 · 2025 $1,723
Food & beverage: $1,468Education: $255
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $449 |
| ABBVIE INC. | 18 | $311 |
| Galderma Laboratories, L.P. | 19 | $251 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $185 |
| Regeneron Healthcare Solutions, Inc. | 5 | $111 |
| PFIZER INC. | 4 | $78 |
| UCB, Inc. | 4 | $70 |
| GENZYME CORPORATION | 2 | $59 |
| Arcutis Biotherapeutics, Inc. | 3 | $55 |
| LEO Pharma Inc. | 2 | $42 |
Products named: TREMFYA, NEMLUVIO, DUPIXENT, RINVOQ, SKYRIZI, ILUMYA, CIBINQO, Bimzelx.
Industry payments across VA — which companies pay providers there.
